ATLANTA, Nov. 9, 2010 /PRNewswire/ -- Segal McCambridge Singer & Mahoney, Ltd. and Greenberg Traurig, LLP obtained three defense verdicts at trial in favor of medical device manufacturer I-Flow Corporation. A federal jury in the United States District Court for the District of Oregon returned defense verdicts on all counts in favor of I-Flow, and against each of three plaintiffs whose cases had been consolidated for trial. The plaintiffs sought between $11 million and $19 million in total damages for alleged permanent, disabling shoulder injuries known as post-arthroscopic glenohumeral chondrolysis (PAGCL). All three plaintiffs claimed that they sustained PAGCL after infusion pumps manufactured by I-Flow were used to infuse local anesthetics into their shoulders following arthroscopic surgeries they underwent in 2004.
After four weeks of evidence and five hours of deliberation, the jury returned three unanimous defense verdicts for I-Flow. The jury found that plaintiffs failed to prove that the pumps were defective, or that there were inadequate warnings related to the pumps or use of them, or that the pumps caused the plaintiffs' alleged injuries. The consolidated cases, Christina McClellan v. I-Flow Corporation, et al., Juan Huerta v. I-Flow Inc., et al., and Danny Arvidson v. DJO, LLC, et al., were decided on Friday, October 15, 2010.
The defense trial team was led by Jeffrey Singer and Mark Crane of Segal McCambridge Singer & Mahoney, Ltd. and Lori Cohen and Scott Campbell of Greenberg Traurig, LLP. The cases are the first in the infusion pump litigation to be tried by this defense team.
|SOURCE Greenberg Traurig, LLP|
Copyright©2010 PR Newswire.
All rights reserved